Kenta Uto

536 total citations
30 papers, 361 citations indexed

About

Kenta Uto is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kenta Uto has authored 30 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Kenta Uto's work include Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Cardiovascular Effects of Exercise (4 papers). Kenta Uto is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Cardiovascular Effects of Exercise (4 papers). Kenta Uto collaborates with scholars based in Japan. Kenta Uto's co-authors include Hideaki Oda, Kazuho Honda, Nobuhisa Hagiwara, Hiroshi Kasanuki, Hirotaka Nagashima, Yasunari Sakomura, Yoshikazu Aoka, Shigeyuki Aomi, Masatoshi Kawana and Toshio Nishikawa and has published in prestigious journals such as Circulation, Hepatology and Scientific Reports.

In The Last Decade

Kenta Uto

27 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenta Uto Japan 11 141 124 86 84 59 30 361
Elliott Chum Canada 6 114 0.8× 116 0.9× 53 0.6× 103 1.2× 36 0.6× 7 343
Rachida Essalihi Canada 6 185 1.3× 83 0.7× 43 0.5× 76 0.9× 47 0.8× 9 408
Susan K. Morton Australia 11 98 0.7× 172 1.4× 115 1.3× 31 0.4× 133 2.3× 17 418
Jiahe Xie China 11 165 1.2× 72 0.6× 242 2.8× 40 0.5× 99 1.7× 14 478
Andrea Grund Germany 13 141 1.0× 40 0.3× 231 2.7× 50 0.6× 78 1.3× 17 458
Zhenhuan Chen China 10 193 1.4× 48 0.4× 204 2.4× 39 0.5× 85 1.4× 16 413
Jun Zou China 13 71 0.5× 71 0.6× 143 1.7× 34 0.4× 39 0.7× 27 400
Jan D. Lanzer Germany 6 83 0.6× 56 0.5× 91 1.1× 26 0.3× 63 1.1× 12 286
Yoko Kikumoto Japan 11 50 0.4× 64 0.5× 58 0.7× 74 0.9× 74 1.3× 12 362
Bernard J. van Varik Netherlands 5 122 0.9× 62 0.5× 32 0.4× 25 0.3× 59 1.0× 6 313

Countries citing papers authored by Kenta Uto

Since Specialization
Citations

This map shows the geographic impact of Kenta Uto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenta Uto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenta Uto more than expected).

Fields of papers citing papers by Kenta Uto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenta Uto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenta Uto. The network helps show where Kenta Uto may publish in the future.

Co-authorship network of co-authors of Kenta Uto

This figure shows the co-authorship network connecting the top 25 collaborators of Kenta Uto. A scholar is included among the top collaborators of Kenta Uto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenta Uto. Kenta Uto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Momose, Mitsuru, Atsushi Yamamoto, Atsushi Suzuki, et al.. (2025). Long term prognosis in cardiac sarcoidosis under FDG-PET guided immunosuppressive therapy. International Journal of Cardiology. 432. 133273–133273. 2 indexed citations
2.
3.
Koyama, Yutaka, Mayumi Suzuki, Kenta Uto, et al.. (2023). Pathology of Critical Limb Ischemia; Comparison of Plaque Characteristics Between Anterior and Posterior Tibial Arteries. Journal of Atherosclerosis and Thrombosis. 30(12). 1893–1904. 2 indexed citations
4.
Shiga, Tsuyoshi, Takako Kamio, Kenta Uto, & Kotaro Arai. (2021). Successful Use of Digoxin for Trastuzumab-related Cardiotoxicity to Facilitate Breast Surgery in a Patient with Metastatic Breast Cancer. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 52(4). 101–105.
5.
Takeuchi, Daiji, Kenta Uto, Kei Inai, Yoji Nagashima, & Takeshi Shinkawa. (2021). Prominent atrial fibrosis and its correlation with atrial tachyarrhythmia and dilated atrium long after classic Fontan surgery. Journal of Cardiology. 79(5). 671–677. 2 indexed citations
6.
Uto, Kenta, et al.. (2020). Pleural changes in patients with pneumothoraces and Marfan syndrome. Journal of Thoracic Disease. 12(9). 4877–4882.
7.
8.
Yamamoto, Tomoko, Kenta Uto, Hiroyuki Arashi, et al.. (2019). Recurrent pericardial effusion with pericardial amyloid deposition: a case report and literature review. Cardiovascular Pathology. 46. 107191–107191. 3 indexed citations
9.
Yoshida, A, Atsushi Suzuki, Takashige Tobita, et al.. (2019). A case of desmoplakin mutation and delayed arrhythmogenic right ventricular cardiomyopathy/dysplasia after atrial septal defect closure. Journal of Cardiology Cases. 19(4). 111–114. 1 indexed citations
10.
Uto, Kenta, et al.. (2019). An autopsy case of giant cell myocarditis showing shared pathology in the myocardium and skeletal muscles. Cardiovascular Pathology. 42. 10–14. 5 indexed citations
11.
Suzuki, Atsushi, Kenta Uto, Kenji Fukushima, et al.. (2018). Successfully treated eosinophilic granulomatosis with polyangiitis relapse presenting as myocarditis and followed by multimodality imaging. Journal of Cardiology Cases. 18(4). 145–148. 5 indexed citations
12.
Tobita, Takashige, Seitaro Nomura, Hiroyuki Morita, et al.. (2017). Identification of MYLK3 mutations in familial dilated cardiomyopathy. Scientific Reports. 7(1). 17495–17495. 23 indexed citations
13.
Suzuki, Atsushi, Tsuyoshi Suzuki, Koichiro Ejima, et al.. (2016). Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography. Journal of Cardiology Cases. 14(4). 107–110. 7 indexed citations
14.
Kikuchi, Noriko, Shinichi Nunoda, Atsushi Suzuki, et al.. (2016). Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. Journal of Cardiology Cases. 13(4). 125–128. 5 indexed citations
15.
Sasaki, Takaaki, Kenta Uto, Norimasa Yamasaki, et al.. (2010). p130Cas, Crk-Associated Substrate Plays Essential Roles in Liver Development by Regulating Sinusoidal Endothelial Cell Fenestration†. Hepatology. 52(3). 1089–1099. 12 indexed citations
16.
Nishikawa, Toshio, Kenta Uto, Hideaki Oda, et al.. (2010). Histopathological aspects of cardiac biopsy in pediatric patients with dilated cardiomyopathy. Pediatrics International. 53(3). 350–353. 4 indexed citations
17.
Nagashima, Hirotaka, Yoshikazu Aoka, Yasunari Sakomura, et al.. (2004). Matrix metalloproteinase 2 is suppressed by trapidil, a CD40–CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. Journal of Vascular Surgery. 39(2). 447–453. 20 indexed citations
18.
Uto, Kenta, et al.. (2002). A Case of Fulminant Type 1 Diabetes Mellitus Detected After Cardiac Arrest due to Diabetic Ketoacidosis.. 45(9). 689–693. 4 indexed citations
19.
Endoh, Yasuhiro, et al.. (2000). Diagnostic Accuracy of KL‐6 as a Marker of Amiodarone‐Induced Pulmonary Toxicity. Pacing and Clinical Electrophysiology. 23(11P2). 2010–2013. 10 indexed citations
20.
Endoh, Yasuhiro, et al.. (2000). KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity. The American Journal of Cardiology. 86(2). 229–231. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elliott Chum Breakdown of academic impact, for papers by Rachida Essalihi Breakdown of academic impact, for papers by Susan K. Morton Breakdown of academic impact, for papers by Jiahe Xie Breakdown of academic impact, for papers by Andrea Grund Breakdown of academic impact, for papers by Zhenhuan Chen Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Jan D. Lanzer Breakdown of academic impact, for papers by Yoko Kikumoto Breakdown of academic impact, for papers by Bernard J. van Varik
Rankless by CCL
2026